AKKARAJU SRINIVAS bought KLRS
May 20, 2026 · Form 4 insider transaction
AKKARAJU SRINIVAS bought 4,471 shares of Kalaris Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as j and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
4,471
Price
$0.00
Total value
N/A
InsiderAKKARAJU SRINIVAS
RoleDirector, 10% owner
SecurityCommon Stock
Transaction codeJ: J
Transaction dateMay 20, 2026
Filing dateMay 22, 2026
Shares owned after19,408
OwnershipIndirect
10b5-1 planNo
AmendedNo
Footnotes
Represents receipt of shares in the distribution in kind described in footnote (3).; Securities are held by Samsara BioCapital Partners. Dr. Akkaraju has voting and investment power over the shares held by Samsara BioCapital Partners and, accordingly, may be deemed to beneficially own the shares held by Samsara BioCapital Partners. Each of the Reporting Persons disclaims beneficial ownership in these shares except to the extent of its or his respective pecuniary interest therein.